These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 36569293)
1. Pan-cancer analysis identifies NT5E as a novel prognostic biomarker on cancer-associated fibroblasts associated with unique tumor microenvironment. Xue XM; Liu YY; Chen XM; Tao BY; Liu P; Zhou HW; Zhang C; Wang L; Jiang YK; Ding ZW; Shen WD; Zhang J; Yang SM; Wang FY Front Pharmacol; 2022; 13():1064032. PubMed ID: 36569293 [No Abstract] [Full Text] [Related]
2. NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment. Chen XM; Liu YY; Tao BY; Xue XM; Zhang XX; Wang LL; Zhong H; Zhang J; Yang SM; Jiang QQ Front Immunol; 2022; 13():975847. PubMed ID: 36091055 [TBL] [Abstract][Full Text] [Related]
3. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related]
4. Identifies microtubule-binding protein Wang W; Zhang J; Wang Y; Xu Y; Zhang S Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625 [TBL] [Abstract][Full Text] [Related]
5. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas. Zhao S; Li Y; Xu J; Shen L Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705 [TBL] [Abstract][Full Text] [Related]
6. Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma. Shen A; Ye Y; Chen F; Xu Y; Zhang Z; Zhao Q; Zeng ZL Front Immunol; 2022; 13():969034. PubMed ID: 36466881 [TBL] [Abstract][Full Text] [Related]
7. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures. Zhang X; Wang Y; A G; Qu C; Chen J Front Immunol; 2021; 12():721030. PubMed ID: 34531868 [TBL] [Abstract][Full Text] [Related]
8. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
9. Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint. Bai KH; Zhang YY; Li XP; Tian XP; Pan MM; Wang DW; Dai YJ Comput Struct Biotechnol J; 2022; 20():5226-5234. PubMed ID: 36187930 [TBL] [Abstract][Full Text] [Related]
10. The molecular feature of macrophages in tumor immune microenvironment of glioma patients. Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502 [TBL] [Abstract][Full Text] [Related]
11. Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance. Ma J; Jin Y; Gong B; Li L; Zhao Q Discov Oncol; 2022 Mar; 13(1):17. PubMed ID: 35312867 [TBL] [Abstract][Full Text] [Related]
12. The cuproptosis-related gene UBE2D2 functions as an immunotherapeutic and prognostic biomarker in pan-cancer. Fei Y; Cao D; Dong R; Li Y; Wang Z; Gao P; Zhu M; Wang X; Zuo X; Cai J Clin Transl Oncol; 2024 Oct; 26(10):2718-2737. PubMed ID: 38703335 [TBL] [Abstract][Full Text] [Related]
13. CDK1 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Pan-Cancer, Especially in Gastrointestinal Tumors. Shen J; Gong X; Tan S; Zhang Y; Xia R; Xu S; Wang S; Zhou H; Jiang Y; Zhao T; Zhang Y; Tang H; Wang C Curr Med Chem; 2024 Jun; ():. PubMed ID: 38952160 [TBL] [Abstract][Full Text] [Related]
14. CD73/NT5E is a Potential Biomarker for Cancer Prognosis and Immunotherapy for Multiple Types of Cancers. Li H; Xie P; Li P; Du Y; Zhu J; Yuan Y; Wu C; Shi Y; Huang Z; Wang X; Liu D; Liu W Adv Biol (Weinh); 2023 Feb; 7(2):e2200263. PubMed ID: 36480312 [TBL] [Abstract][Full Text] [Related]
15. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression. Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X Front Oncol; 2022; 12():927988. PubMed ID: 35756681 [TBL] [Abstract][Full Text] [Related]
16. Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis. Guo L; Li S; Qian B; Wang Y; Duan R; Jiang W; Kang Y; Dou Y; Yang G; Shen L; Wang J; Liang T Comput Struct Biotechnol J; 2020; 18():3243-3254. PubMed ID: 33240468 [TBL] [Abstract][Full Text] [Related]
17. A Pan-Cancer Analysis of the Oncogenic Role of Yang D; Li H; Chen Y; Li C; Ren W; Huang Y Front Genet; 2022; 13():906174. PubMed ID: 35910232 [No Abstract] [Full Text] [Related]
18. The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression. Zhang Z; Li L; Li M; Wang X Comput Struct Biotechnol J; 2020; 18():2438-2444. PubMed ID: 32905022 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Prediction, Immune Microenvironment, and Drug Resistance Value of Collagen Type I Alpha 1 Chain: From Gastrointestinal Cancers to Pan-Cancer Analysis. Liu Y; Xue J; Zhong M; Wang Z; Li J; Zhu Y Front Mol Biosci; 2021; 8():692120. PubMed ID: 34395525 [No Abstract] [Full Text] [Related]
20. CRABP2 regulates infiltration of cancer-associated fibroblasts and immune response in melanoma. Zeng S; Chen XI; Yi Q; Thakur A; Yang H; Yan Y; Liu S Oncol Res; 2023; 32(2):261-272. PubMed ID: 38186580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]